Treatment of endometriosis
OA: closed
AI-generated summary
This paper describes compositions and packages for treating endometriosis that combine an LHRH agonist to induce a hypoestrogenic state with a progestational agent to cause implant decidualization, fibrosis, necrosis, and absorption.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis may be treated with LHRH or an agonist thereof to create a hypoestrogenic state and a progestational agent to cause decidualization, fibrosis, necrosis and absorption of the implant. Compositions and packages for use in treating endometriosis contain LHRH or an agonist thereof and a progestational agent.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-07-31T06:09:14.520117+00:00